Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

proMMP-3

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
OBJECTIVE Extracellular matrix metalloproteinase inducer (EMMPRIN) is highly expressed on malignant tumor cell surface and… Expand
Highly Cited
2008
Highly Cited
2008
We have previously demonstrated that the active form of matrix metalloproteinase‐3 (actMMP‐3) is released from dopamine(DA)rgic… Expand
Highly Cited
2002
Highly Cited
2002
Forces applied to tendon during movement cause cellular deformation, as well as fluid movement. The goal of this study was to… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 5
Highly Cited
2001
Highly Cited
2001
OBJECTIVE To assess how serum concentrations of some cytokines, proteases and their inhibitors and cartilage oligomeric matrix… Expand
2000
2000
OBJECTIVE To determine if there is a relationship between serum pro-matrix metalloproteinase-3 (proMMP-3) levels and radiographic… Expand
1996
1996
The precursor of matrix metalloproteinase 3 (MMP-3/stromelysin 1) is activated in vitro by proteinases or mercurial compounds by… Expand
1996
1996
The mechanisms by which epidermal growth factor (EGF) enhances the production of pro‐matrix metalloproteinase 3 (proMMP‐3… Expand
Highly Cited
1994
Highly Cited
1994
OBJECTIVE--To investigate if the increased concentrations of stromelysin (MMP-3) found in the synovial fluid (SF) of patients… Expand
Highly Cited
1993
Highly Cited
1993
Matrix metalloproteinases (MMPs) are activated in vitro from their precursors (proMMPs) by multiple means such as treatment with… Expand
Highly Cited
1991
Highly Cited
1991
Two zymogens of matrix metalloproteinases (MMPs), proMMP-1 (tissue procollagenase) and proMMP-3 (prostromelysin) were isolated… Expand